Used in the pharmaceutical industry as an intermediate in the synthesis of antiviral drugs, particularly in the development of treatments targeting RNA viruses. Its structure supports binding to viral protease enzymes, making it valuable in creating inhibitors that disrupt viral replication. Commonly employed in research settings for optimizing drug candidates with improved bioavailability and metabolic stability. Also utilized in structure-activity relationship (SAR) studies to enhance potency and selectivity against specific viral targets.